We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing

News   Mar 10, 2017 | Original Story from ImmunoMet

 
ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing
 
 
Advertisement
 

RELATED ARTICLES

Amarna Therapeutics Appoints Kite Pharma Veteran Dr. Markwin Velders to its Supervisory Board

News

Amarna Therapeutics today announced the appointment of former VP Operations and Managing Director at Kite Pharma EU, Dr. Markwin Velders to its Supervisory Board.

READ MORE

Common Diabetes Drugs May Help Prevent Parkinson’s Disease, Large Study Finds

News

Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by UCL researchers.

READ MORE

Understanding Autoimmune Psychosis

News

A new study by the University of Barcelona (UB) and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) shows autoimmune brain illness would be caused by alterations in the quantity of dopaminergic receptors D1R and D2R in the hippocampal area of the brain.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE